DaVita
DVA
#1636
Rank
S$17.19 B
Marketcap
S$267.88
Share price
-0.37%
Change (1 day)
51.09%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): S$14.10

According to DaVita's latest financial reports the company's current EPS (TTM) is S$14.10. In 2025 the company made an earnings per share (EPS) of S$12.97 a decrease over its 2024 EPS that were of S$14.14.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$14.108.72%
2025S$12.97-8.25%
2024S$14.1444.94%
2023S$9.7527.26%
2022S$7.67-35.56%
2021S$11.9044.1%
2020S$8.2519.7%
2019S$6.90540.48%
2018S$1.08-76.07%
2017S$4.50-19.31%
2016S$5.58242.52%
2015S$1.63-62.87%
2014S$4.3813.43%
2013S$3.868.45%
2012S$3.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
S$31.16 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$14.56 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
S$24.93 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.47-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA